BEGIN:VCALENDAR VERSION:2.0 PRODID:IEEE vTools.Events//EN CALSCALE:GREGORIAN BEGIN:VTIMEZONE TZID:Turkey BEGIN:DAYLIGHT DTSTART:20380119T061407 TZOFFSETFROM:+0300 TZOFFSETTO:+0300 RRULE:FREQ=YEARLY;BYDAY=3TU;BYMONTH=1 TZNAME:+03 END:DAYLIGHT BEGIN:STANDARD DTSTART:20160907T000000 TZOFFSETFROM:+0300 TZOFFSETTO:+0300 RRULE:FREQ=YEARLY;BYDAY=1WE;BYMONTH=9 TZNAME:+03 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTAMP:20191217T183008Z UID:BFD5D982-94B5-4C0A-BCCA-0AEDF7670B12 DTSTART;TZID=Turkey:20191213T124000 DTEND;TZID=Turkey:20191213T143000 DESCRIPTION:13 December 2019 (12:40): IEEE AP/MTT/EMC/ED Turkey Seminar Ser ies (S.62)\n\nSpeaker: Asst. Prof. Arif Engin Çetin\, İzmir Biomedicine and Genome Center\n\nTopic: "The Use of Optics and Nano-Plasmonics for Poi nt-of-Care Analysis in Resource-Poor Settings"\n\nLocation: Middle East Te chnical University\, Ankara\, Turkey\n\nAbstract: In this talk\, I will in troduce portable and low-cost plasmonic biosensor platforms for resource-p oor settings.\n\nIn recent years\, research on plasmonic systems to overco me the limitations of biosensors brought new functionalities that do not e xist in the traditional optical approaches. New generation plasmonic biose nsor systems enable real-time detection of biomolecules at very low analyt e concentrations without the need for optical labels. These systems stimul ate optical responses with very sensitivity and high quality factor by emp loying surface plasmons\, which are powerful surface electromagnetic waves \, strongly localized in nanometer scale. Employing surface plasmons\, con ventional detectors\, e.g.\, spectrometers\, can be used to distinguish si gnal variations generated by the targeted biomolecules of interest.\n\nIn conventional spectrometer-based biosensing systems based on refractive ind ex sensing\, the presence of biomolecules in the samples are determined by monitoring the spectral shifts within the plasmonic responses. These plat forms enable the detection of analytes\, e.g.\, viruses or bacteria\, at m edically relevant concentrations that need to be identified for disease di agnostics in clinics\, with simpler sample preparation protocols. Multiple xing and high-throughput capability of biosensors can be improved by integ rating large-scale and high-density plasmonic chips to imaging-based platf orms. By integrating plasmonic nano-chips into a telemedicine platform\, t hese new generation plasmonic biosensors can be transformed into a portabl e platform to be deployed in resource-poor settings. These platforms can b e also integrated to portable read-out devices\, e.g.\, laptops or mobile phones\, to provide highly sensitive label-free biosensing in inadequate m edical infrastructure.\n\nBy integrating microfluidic technologies with po rtable plasmonic biosensing platforms\, real-time analysis of protein-prot ein interaction kinetics can be also demonstrated in a cost-effective mann er. Using powerful data processing algorithms\, our microfluidic technolog y can monitor biomolecular binding interactions at pico-molar concentratio n levels.\n\nBio: Arif E. Cetin is a Research Group Leader in Izmir Biomed icine and Genome Center (IBG)\, Izmir\, Turkey. Dr. Cetin received his BS degree in Electrical and Electronics Engineering and MS degree in Electric al and Computer Engineering both from Koc University\, Istanbul\, Turkey. He received his PhD degree in Electrical Engineering from Boston Universit y\, Boston\, MA\, USA. He worked as a postdoctoral fellow at EPFL\, Lausan ne\, Switzerland in 2013–2014 and at MIT\, Cambridge\, MA\, USA in 2014 –2016\, and as a research scientist at Omniome\, Inc. San Diego\, CA\, U SA in 2016–2018.\n\nDr. Cetin is pursuing research on optical nano-biose nsors integrated with microfluidic platforms. He is developing hand-held b iosensors for high-throughput and multiplexed biosensing. Recently\, he is also developing a unique label-free technique for high-throughput DNA seq uencing.\n\nSpeaker(s): Asst. Prof. Arif Engin Cetin\, \n\nAnkara\, Ankara \, Türkiye LOCATION:Ankara\, Ankara\, Türkiye ORGANIZER:ozergul@metu.edu.tr SEQUENCE:0 SUMMARY:IEEE AP/MTT/EMC/ED TURKEY CHAPTER SEMINAR SERIES -- SEMINAR 62 URL;VALUE=URI:https://events.vtools.ieee.org/m/214780 X-ALT-DESC:Description: <br /><p><strong>13 December 2019 (12:40): &nbsp\;I EEE AP/MTT/EMC/ED Turkey Seminar Series (S.62)</strong></p>\n<p>Speaker: A sst. Prof. Arif Engin &Ccedil\;etin\, İzmir Biomedicine and Genome Center </p>\n<p>Topic: "The Use of Optics and Nano-Plasmonics for Point-of-Care A nalysis in Resource-Poor Settings"</p>\n<p>Location:&nbsp\;Middle East Tec hnical University\, Ankara\, Turkey</p>\n<p>Abstract: In this talk\, I wil l introduce portable and low-cost plasmonic biosensor platforms for resour ce-poor settings.</p>\n<p>In recent years\, research on plasmonic systems to overcome the limitations of biosensors brought new functionalities that do not exist in the traditional optical approaches. New generation plasmo nic biosensor systems enable real-time detection of biomolecules at very l ow analyte concentrations without the need for optical labels. These syste ms stimulate optical responses with very sensitivity and high quality fact or by employing surface plasmons\, which are powerful surface electromagne tic waves\, strongly localized in nanometer scale. Employing surface plasm ons\, conventional detectors\, e.g.\, spectrometers\, can be used to disti nguish signal variations generated by the targeted biomolecules of interes t.</p>\n<p>In conventional spectrometer-based biosensing systems based on refractive index sensing\, the presence of biomolecules in the samples are determined by monitoring the spectral shifts within the plasmonic respons es. These platforms enable the detection of analytes\, e.g.\, viruses or b acteria\, at medically relevant concentrations that need to be identified for disease diagnostics in clinics\, with simpler sample preparation proto cols. Multiplexing and high-throughput capability of biosensors can be imp roved by integrating large-scale and high-density plasmonic chips to imagi ng-based platforms. By integrating plasmonic nano-chips into a telemedicin e platform\, these new generation plasmonic biosensors can be transformed into a portable platform to be deployed in resource-poor settings. These p latforms can be also integrated to portable read-out devices\, e.g.\, lapt ops or mobile phones\, to provide highly sensitive label-free biosensing i n inadequate medical infrastructure.</p>\n<p>By integrating microfluidic t echnologies with portable plasmonic biosensing platforms\, real-time analy sis of protein-protein interaction kinetics can be also demonstrated in a cost-effective manner. Using powerful data processing algorithms\, our mic rofluidic technology can monitor biomolecular binding interactions at pico -molar concentration levels.</p>\n<p>Bio: Arif E. Cetin is a Research Grou p Leader in Izmir Biomedicine and Genome Center (IBG)\, Izmir\, Turkey. Dr . Cetin received his BS degree in Electrical and Electronics Engineering a nd MS degree in Electrical and Computer Engineering both from Koc Universi ty\, Istanbul\, Turkey. He received his PhD degree in Electrical Engineeri ng from Boston University\, Boston\, MA\, USA. He worked as a postdoctoral fellow at EPFL\, Lausanne\, Switzerland in 2013&ndash\;2014 and at MIT\, Cambridge\, MA\, USA in 2014&ndash\;2016\, and as a research scientist at Omniome\, Inc. San Diego\, CA\, USA in 2016&ndash\;2018.</p>\n<p>Dr. Cetin is pursuing research on optical nano-biosensors integrated with microflui dic platforms. He is developing hand-held biosensors for high-throughput a nd multiplexed biosensing. Recently\, he is also developing a unique label -free technique for high-throughput DNA sequencing.</p> END:VEVENT END:VCALENDAR